High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge

Open Access

Peer-reviewed

Research Article

Christopher T. Campbell,

Affiliation Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America
⨯
Sean R. Llewellyn,

Affiliation Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America
⨯
Thorsten Damberg,

Affiliation Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
Ian L. Morgan,

Affiliation Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
Marjorie Robert-Guroff ,

* E-mail: guroffm@mail.nih.gov (JCG); gildersj@mail.nih.gov (MR)

Affiliation Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
Jeffrey C. Gildersleeve

* E-mail: guroffm@mail.nih.gov (JCG); gildersj@mail.nih.gov (MR)

Affiliation Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America
⨯

Reader Comments (0)

Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Macaque
Is the Subject Area "Macaque" applicable to this article?

Thanks for your feedback.
SIV
Is the Subject Area "SIV" applicable to this article?

Thanks for your feedback.
HIV vaccines
Is the Subject Area "HIV vaccines" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Antibody response
Is the Subject Area "Antibody response" applicable to this article?

Thanks for your feedback.
Microarrays
Is the Subject Area "Microarrays" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.